A randomized controlled trial of levosimendan to reduce mortality in high-risk cardiac surgery patients (CHEETAH): Rationale and design

American Heart Journal

Volumn 177, Issue , 2016, Pages 66-73

  Zangrillo, Alberto ^a,c   Alvaro, Gabriele ^d   Pisano, Antonio ^e   Guarracino, Fabio ^f   Lobreglio, Rosetta ^g   Bradic, Nikola ^h   Lembo, Rosalba ^a   Gianni, Stefano ^a   Calabrò, Maria Grazia ^a   Likhvantsev, Valery ⁱ   Grigoryev, Evgeny ^j   Buscaglia, Giuseppe ^k   Pala, Giovanni ^l   Auci, Elisabetta ⁿ   Amantea, Bruno ^d   Monaco, Fabrizio ^a   De Vuono, Giovanni ^d   Corcione, Antonio ^m   Galdieri, Nicola ^e   Cariello, Claudia ^f   Bove, Tiziana ^a   Fominskiy, Evgeny ^a   Auriemma, Stefano ⁿ   Baiocchi, Massimo ^o   Bianchi, Alessandro ^p   Frontini, Mario ^q   Paternoster, Gianluca ^r   Sangalli, Fabio ^s   Wang, Chew Yin ^t   Zucchetti, Maria Chiara ^u   Biondi Zoccai, Giuseppe ^v,w   Gemma, Marco ^a   Lipinski, Michael J ^x   Lomivorotov, Vladimir V ^y   Landoni, Giovanni ^a,b   more..

^a SAN RAFFAELE HOSPITAL   (Italy)

^b VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

^c Magna Grecia University   (Italy)

^d MONALDI HOSPITAL   (Italy)

^e UNIVERSITY HOSPITAL OF PISA   (Italy)

^f CITTÀ DELLA SALUTE E DELLA SCIENZA HOSPITAL   (Italy)

^g University of Zagreb   (Croatia)

^h Research Institute   (Russian Federation)

ⁱ RESEARCH INSTITUTE FOR COMPLEX ISSUES OF CARDIOVASCULAR DISEASES   (Russian Federation)

^j UNIVERSITY OF GENOA   (Italy)

^k SS Annunziata Hospital   (Italy)

^l SANTA MARIA DELLA MISERICORDIA UNIVERSITY HOSPITAL   (Italy)

^m AORN Ospedale dei Colli   (Italy)

ⁿ SAN BORTOLO HOSPITAL   (Italy)

^o UNIVERSITY OF BOLOGNA   (Italy)

^p MAURIZIANO HOSPITAL   (Italy)

^q SPEDALI CIVILI   (Italy)

^r SAN CARLO HOSPITAL   (Italy)

^s SAN GERARDO HOSPITAL   (Italy)

^t UNIVERSITY OF MALAYA   (Malaysia)

^u Azienda Ospedaliera Piemonte Papardo   (Italy)

^v SAPIENZA UNIVERSITY OF ROME   (Italy)

^w IRCCS   (Italy)

^x WASHINGTON HOSPITAL CENTER   (United States)

^y MESHALKIN NATIONAL MEDICAL RESEARCH CENTER   (Russian Federation)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; DOBUTAMINE; DOPAMINE; ENOXIMONE; LEVOSIMENDAN; NORADRENALIN; PLACEBO; CARDIOTONIC AGENT; HYDRAZONE DERIVATIVE; PYRIDAZINE DERIVATIVE; SIMENDAN;

ACUTE KIDNEY FAILURE; ADULT; ARTICLE; ARTIFICIAL VENTILATION; CARDIOVASCULAR MORTALITY; CHILD SAFETY; CONTINUOUS INFUSION; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG MEGADOSE; FOLLOW UP; FORWARD HEART FAILURE; HEART SURGERY; HUMAN; INTRAAORTIC BALLOON PUMP; MAJOR CLINICAL STUDY; META ANALYSIS (TOPIC); MULTICENTER STUDY; MYOCARDIAL DISEASE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RENAL REPLACEMENT THERAPY; SURGICAL MORTALITY; SURGICAL PATIENT; TERTIARY CARE CENTER; UNSPECIFIED SIDE EFFECT; ACUTE KIDNEY INJURY; CARDIAC OUTPUT, LOW; CLINICAL TRIAL; INTENSIVE CARE UNIT; INTRAVENOUS DRUG ADMINISTRATION; LENGTH OF STAY; MORTALITY; POSTOPERATIVE COMPLICATIONS; STATISTICS AND NUMERICAL DATA;

ACUTE KIDNEY INJURY; CARDIAC OUTPUT, LOW; CARDIAC SURGICAL PROCEDURES; CARDIOTONIC AGENTS; DOUBLE-BLIND METHOD; HUMANS; HYDRAZONES; INFUSIONS, INTRAVENOUS; INTENSIVE CARE UNITS; INTRA-AORTIC BALLOON PUMPING; LENGTH OF STAY; POSTOPERATIVE COMPLICATIONS; PYRIDAZINES; RESPIRATION, ARTIFICIAL;

EID: 84966441045     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2016.03.021     Document Type: Article

References (40)

1. A. Mebaaza, A.A. Pitsis, A. Rudiger, and et al. Clinical review: practical recommendations on the management of perioperative heart failure in cardiac surgery Crit Care 14 2010 201
2. A. Denault, J.C. Tardif, D. Mazer, and et al. Difficult and complex separation from cardiopulmonary bypass in high-risk cardiac surgical patients: a multicenter study J Cardiothorac Vasc Anesth 26 2012 608 616
3. A. Zangrillo, G. Biondi-Zoccai, A. Mizzi, and et al. Levosimendan reduces cardiac troponin release after cardiac surgery: a meta-analysis of randomized controlled studies J Cardiothorac Vasc Anesth 23 2009 474 478
4. G. Landoni, A. Mizzi, G. Biondi-Zoccai, and et al. Reducing mortality in cardiac surgery with levosimendan: a meta-analysis of randomized controlled trials J Cardiothorac Vasc Anesth 24 2010 51 57
5. G. Landoni, G. Biondi-Zoccai, M. Greco, and et al. Effects of levosimendan on mortality and hospitalization. A meta-analysis of randomized controlled studies Crit Care Med 40 2012 634 646
6. F. Balzer, S. Treskatsch, C. Spies, and et al. Early administration of levosimendan is associated with improved kidney function after cardiac surgery a retrospective analysis J Cardiothorac Surg 9 2014 167
7. A. Baysal, M. Yanartas, M. Dogukan, and et al. Levosimendan improves renal outcome in cardiac surgery: a randomized trial J Cardiothorac Vasc Anesth 28 2014 586 594
8. S. Thackray, J. Easthaugh, N. Freemantle, and et al. The effectiveness and relative effectiveness of intravenous inotropic drugs acting through the adrenergic pathway in patients with heart failure - a meta-regression analysis Eur J Heart Fail 4 2002 515 529
9. J.R. Teerlink Overview of randomized clinical trials in acute heart failure syndromes Am J Cardiol 96 2005 59G 67G
10. M. Bayram, L. De Luca, M.B. Massie, and et al. Reassessment of dobutamine, dopamine, and milrinone in the management of acute heart failure syndromes Am J Cardiol 96 2005 47G 58G
11. Greco T, Calabrò MG, Covello RD, et al. A Bayesian network meta-analysis on the effect of inodilatory agents on mortality. Br J Anaesth 114, 2015, 746-56.
12. R.W. Harrison, V. Hasselblad, R.H. Mehta, and et al. Effect of levosimendan on survival and adverse events after cardiac surgery: a meta-analysis J Cardiothorac Vasc Anesth 27 2013 1224 1232
13. W.G. Toller, and C. Stranz Levosimendan, a new inotropic and vasodilator agent Anesthesiology 104 2006 556 569
14. M.S. Nieminen, S. Fruhwald, L.M.A. Heunks, and et al. Levosimendan: current data, clinical use and future development Heart Lung Vessel 5 2013 227 245
15. P. Pollesello, and Z. Papp The cardioprotective effects of levosimendan: preclinical and clinical evidence J Cardiovasc Pharmacol 50 2007 257 263
16. J.T. Parissis, I. Andreadou, V. Bistola, and et al. Novel biologic mechanisms of levosimendan and its effect on the failing heart Expert Opin Investig Drugs 17 2008 1143 1150
17. 2+-sensitizer levosimendan improves oxidative damage, BNP and pro-inflammatory cytokine levels in patients with advanced decompensated heart failure in comparison to dobutamine Eur J Heart Fail 7 2005 882 887
18. E. Cuneyt, Y. Senol, T. Faruk, and et al. Preoperative usages of levosimendan in patients undergoing coronary artery bypass grafting Int J Clin Exp Med 7 2014 219 229
19. P. Sharma, A. Malhotra, S. Gandhi, and et al. Preoperative levosimendan in ischemic mitral valve repair Asian Cardiovasc Thorac Ann 22 2013 539 545
20. J.Y. Lim, S.V. Deo, A. Rababa'h, and et al. Levosimendan reduces mortality in adults with left ventricular dysfunction undergoing cardiac surgery: a systematic review and meta-analysis J Card Surg 30 2015 547 554
21. W. Toller, M. Heringlake, F. Guarracino, and et al. Preoperative and perioperative use of levosimendan in cardiac surgery: European expert opinion Int J Cardiol 184 2015 323 336
22. M. Packer, W. Colucci, L. Fisher, and et al. Effect of levosimendan on the short-term clinical course of patients with acutely decompensated heart failure JACC Heart Fail 1 2013 103 111
23. A. Mebazaa, M. Nieminen, M. Packer, and et al. Levosimendan vs dobutamine for patients with acute decompensated heart failure: the SURVIVE randomized trial JAMA 297 2007 1883 1891
24. S. Silvetti, T. Greco, A.L. Di Prima, and et al. Intermittent levosimendan improves mid-term survival in chronic heart failure patients: meta-analysis of randomized trials Clin Res Cardiol 103 2014 505 513
25. R. Levin, M. Degrange, C. Del Mazo, and et al. Preoperative levosimendan decreases mortality and the development of low cardiac output in high-risk patients with severe left ventricular dysfunction undergoing coronary artery bypass grafting with cardiopulmonary bypass Exp Clin Cardiol 17 2012 125 130
26. I. Ikonomidis, J.T. Parissis, I. Paraskevaidis, and et al. Effects of levosimendan on coronary artery flow and cardiac performance in patients with advanced heart failure Eur J Heart Fail 9 2007 1172 1177
27. G. Wernovsky, D. Wypij, R.A. Jonas, and et al. Postoperative course and hemodynamic profile after the arterial switch operation in neonates and infants. A comparison of low- flow cardiopulmonary bypass and circulatory arrest Circulation 92 1995 2226 2235
28. A. Haque, N.R. Siddiqui, O. Munir, and et al. Association between vasoactive-inotropic score and mortality in pediatric septic shock Indian Pediatr 52 2015 311 313
29. M.G. Gaies, J.G. Gurney, A.H. Yen, and et al. Vasoactive-inotropic score as a predictor of morbidity and mortality in infants after cardiopulmonary bypass Pediatr Crit Care Med 11 2010 234 238
30. Wu V.C., Tsai H.B., Yeh Y.C., et al. Patients supported by extracorporeal membrane oxygenation and acute dialysis: acute physiology and chronic health evaluation score in predicting hospital mortality. Artif Organs 34, 2010, 828-835.
31. R.U. Garcia, H.L. Walters III, R.E. Delius, and et al. Vasoactive inotropic score (VIS) as biomarker of short-term outcomes in adolescents after cardiothoracic surgery Pediatr Cardiol 37 2016 271 277
32. F. Pappalardo, M. Pieri, B. Arnaez Corada, and et al. Timing and strategy for weaning from venoarterial ECMO are complex issues J Cardiothorac Vasc Anesth 29 2015 906 911
33. T. Bove, A. Zangrillo, F. Guarracino, and et al. Effect of fenoldopam on use of renal replacement therapy among patients with acute kidney injury after cardiac surgery: a randomized clinical trial JAMA 312 2014 2244 2253
34. J. Puttonen, S. Kantele, M. Kivikko, and et al. Effect of severe renal failure and hemodialysis on the pharmacokinetics of levosimendan and its metabolites Clin Pharmacokinet 46 2007 235 246
35. T. Bove, A. Matteazzi, A. Belletti, and et al. Beneficial impact of levosimendan in critically ill patients with or at risk for acute renal failure: a meta-analysis of randomized clinical trials Heart Lung Vessel 7 2015 35 46
36. D.L. DeMets, S.J. Pocock, and D.G. Julian The agonising negative trend in monitoring of clinical trials Lancet 354 1999 1983 1988
37. R.G. Newcombe Interval estimation for the difference between independent proportions: comparison of eleven methods Stat Med 17 1998 873 890
38. S.G. De Hert, S. Lorsomradee, H. VandenEede, and et al. A randomized trial evaluating different modalities of levosimendan administration in cardiac surgery patients with myocardial dysfunction J Cardiothorac Vasc Anesth 22 2008 699 705
39. K. Järvelä, P. Maaranen, T. Sisto, and et al. Levosimendan in aortic valve surgery: cardiac performance and recovery J Cardiothorac Vasc Anesth 22 2008 693 698
40. A. Belletti, M.L. Castro, S. Silvetti, and et al. The effect of inotropes and vasopressors on mortality: a meta-analysis of randomized clinical trials Br J Anaesth 115 2015 656 675